Wealth 
Online
|
|||||||
 | |||||||
| Price + |
| Intraday Chart |
| Financials |
| News |
| Messages |
| Reports |
| Block Deals |
| Corporate Announcements |
| MF Holdings |
| Compare with Peer |
Market Round Up
Pre Market Cues
From CNBC-TV18
More News & Analysis
Orchid receives US FDA approval for Cefuroxime Axetil ANDA
2008-02-20 13:05:11 Source : Moneycontrol.com
| ads by google |
The Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid) today announced that it has received approval from the US FDA for its ANDA (Abbreviated New Drug Application) for Cefuroxime Axetil Tablets. The product is available in three dosage strengths, 125 mg, 250 mg and 500 mg.
This is the 25th ANDA approval that Orchid has received since it started its US Generics journey in 2005.
Sourced From: Orchid Chemicals & Pharmaceuticals Ltd
|
 |
|  |
| Related links: | |
 |
 |
 |
Related Stories
Rate this article
- Jul 09, 16:00
- Last Price
- Change
- Volume
- BSE
- Rs.265.65
4.60 1.76%- 360501
- NSE
- Rs.261.15
- 1.20 0.46%
- 1004670
- Messages
- Add to:
 |
on Orchid Chemical |
 |
Have a tip or opinion? | Post your view |
MF View on Orchid Chemical  |
|
Are MFs buying or dumping Orchid Chemical? |
|
Are Fund Managers betting on Pharmaceuticals sector? |
Most Popular
Top Rated
Editor's Pick
| |||||||||||||||||||||||||||||||||
